Corporate America’s China addiction has become a national security threat

Supply Chain Vulnerabilities: How Corporate Dependence on Beijing Threatens American Security

Corporate America s China addiction has become - A growing consensus exists among policymakers and business leaders that the United States faces mounting risks from its economic entanglement with Communist China. Despite widespread recognition of this problem, meaningful action remains elusive. One promising avenue involves enhancing transparency requirements for publicly traded corporations. A formal petition submitted to the Securities and Exchange Commission calls for mandatory disclosure of supply chain vulnerabilities tied to Chinese dependencies. Shareholders deserve comprehensive visibility into how exposed American corporations have become to geopolitical instability.

This situation extends beyond theoretical scenarios or simulated exercises. American enterprises have transferred essential manufacturing capabilities to a strategic competitor determined to supplant U.S. global leadership. Taiwan represents a potential flashpoint that could escalate rapidly. The fragility of current supply networks means that sudden disruptions—whether through military conflict, trade embargoes, or economic pressure—could paralyze critical sectors including defense manufacturing, healthcare delivery, technology production, and consumer goods within hours.

SEN TODD YOUNG: THE HIDDEN DANGER CHINA'S SHIPS COULD BRING TO OUR SHORES

Beijing maintains commanding positions across numerous vital resource categories. Approximately seventy percent of worldwide rare earth element mining occurs within Chinese territory, while processing operations handle over ninety percent of these materials. American military and civilian infrastructure depends heavily on Chinese-sourced minerals for F-35 fighter aircraft, submarine systems, missile guidance components, semiconductor fabrication, electric vehicle batteries, and medical equipment manufacturing. Beijing's recent export restrictions serve as practical demonstrations of potential leverage rather than mere warnings.

The pharmaceutical industry faces comparable exposure levels. Chinese manufacturers provide between sixty and seventy percent or more of active pharmaceutical ingredients and precursor substances used in antibiotics and other essential medications. Indian pharmaceutical producers, which supply much of the remaining global market, rely substantially on Chinese raw materials themselves. During emergency situations, American medical facilities, retail pharmacies, and military treatment centers would encounter immediate supply constraints.

STEVE MOORE: POLITICIANS ARE BLAMING THE WRONG VILLAIN FOR AMERICA'S RISING FOOD PRICES

Such disruptions would transcend simple economic inconvenience, potentially triggering comprehensive health emergencies across the nation. American corporations prioritized cost reduction and transferred practical expertise, manufacturing equipment, production methodologies, and market positioning to Beijing. According to observations published by The New York Times, this strategy enabled a competitor to achieve dominance across rare-earth magnet production, solar panel manufacturing, steel fabrication, pharmaceutical development, and electric vehicle assembly. Profit maximization never represented Beijing's exclusive objective; achieving strategic supremacy remained equally important.

Historical precedents validate this assessment. In 2010, China imposed rare earth export restrictions on Japan following a territorial disagreement, extracting political concessions without military engagement. More recently, Beijing limited shipments of gallium, germanium, and additional materials in response to American policy actions. Chinese authorities are systematically mapping international supply networks through licensing mandates to identify potential pressure points for future economic coercion.

Existing corporate reporting mechanisms prove insufficient for addressing these challenges. Companies frequently avoid alarming investors or attracting regulatory attention despite understanding underlying risks. This caution fails to meet fiduciary obligations and statutory disclosure requirements. Portfolio valuation becomes difficult when SEC documentation minimizes scenarios involving sudden loss of access to seventy to ninety percent of essential inputs. Policymakers similarly lack adequate information when evaluating sanctions effectiveness, tariff impacts, or defense preparedness strategies.

The SEC possesses established authority to require more precise reporting regarding geographic concentration risks, single-source dependencies, and scenario projections for significant supply interruptions. Corporations should calculate potential revenue losses, cost increases, and operational disruptions resulting from China-specific emergencies. Generic references to "geopolitical tensions" no longer satisfy investor needs. While critics argue such requirements burden commercial operations or introduce political considerations into market functioning, accurate information enables better capital allocation decisions. Concealing fundamental supply chain weaknesses distorts investment patterns and leaves shareholders vulnerable to unexpected shocks.

Free enterprise principles do not demand ignoring unique risks associated with commercial relationships involving authoritarian competitors pursuing global dominance. National security considerations and economic resilience represent material facts rather than peripheral concerns. Recognizing that China employs a strategy of "fighting without fighting"—deliberately weaponizing trade relationships developed across multiple decades—provides essential context for understanding current vulnerabilities and developing appropriate responses.